Omron Healthcare and physIQ Partner to Transform Cardiovascular Patient Care

  • Omron HeartGuide®, the first wearable blood pressure
    device, will integrate with physIQ’s pinpointIQ® analytics
    platform to indicate a potential health risk
  • This combined solution is being deployed to help manage
    recently-discharged, at-risk patients
  • The goal is to provide clinicians with physiological insight to
    proactively address potential clinical deterioration

CHICAGO–(BUSINESS WIRE)–lt;a href=”” target=”_blank”gt;#ClinicalTriallt;/agt;–Omron Healthcare, Inc. and physIQ
today announced a collaboration to integrate Omron’s innovative
FDA-cleared device, HeartGuide®, the first wearable blood
pressure monitor into the pinpointIQ® platform
to monitor at-risk patients in an outpatient setting. The strategic
collaboration aims to generate actionable clinical information for
at-risk patients in an outpatient environment by leveraging the
complementary technologies of each company. Omron is the global leader
in personal heart health and wellness technology and physIQ is a pioneer
in FDA-cleared Artificial
Intelligence physiology analytics

The Omron HeartGuide, which recently announced its retail availability
at the 2019 Consumer Electronics Show (CES) and awarded the Engadget
“Best of CES” award for best wearable, is a first-of-its kind wearable
blood pressure monitor made in the convenient form of a wristwatch. It
uses oscillometric technology to measure medically-accurate blood
pressure readings and monitors activity and sleep. PhysIQ’s pinpointIQ
solution is an enterprise-ready, device-agnostic platform designed to
capture continuous multivariate physiological data from wearable
sensors, apply FDA-cleared Artificial Intelligence-based analytics, and
provide actionable clinical information to a patient’s care team.
Collectively, the combined solution represents an opportunity to enable
a proactive care delivery model to better support at-risk patients at

“At Omron, our mission is Going for Zero, the elimination of heart
attack and stroke,” said Ranndy Kellogg, president and CEO of Omron
Healthcare. “HeartGuide is a significant step forward in Going for Zero
and the addition of advanced analytics builds on that advancement to
give even higher risk patients greater power in managing their condition
and reducing their risk of an event. We are committed to working with
physIQ to leverage their industry-leading platform and human physiology
analytics to provide better care for patients.”

The initial implementation of the combined solution will be with a major
Chicago-area integrated health system and focus on supporting
post-discharge patients who have been hospitalized for either heart
failure or heart attack. Patients will wear HeartGuide, which will
transmit data through the physIQ mobile app to the pinpointIQ
cloud-based platform. Clinicians will access patient data and analytics
through the pinpointIQ user interface such that they can
proactively manage their at-risk patients.

“We have long believed that high-frequency ‘real world’ blood pressure
was a parameter that could unlock unprecedented visibility into patient
physiology,” shared Gary Conkright, CEO of physIQ. “By integrating
HeartGuide into our pinpointIQ platform, we are confident that we
have an end-to-end solution that will address a massive unmet need in
the market and bring enormous value to patients and their clinicians.
This is the beginning of a relationship that we believe will truly
transform how patients are cared for at home.”

Cardiovascular disease is the leading cause of death in the U.S. with
Americans suffering 760,000 heart attacks each year. In addition, 5.7
million adults live with heart failure, resulting in more than 1 million
hospitalizations annually. By virtue of continuously capturing clinical
grade data and leveraging machine learning-based analytics, Omron and
physIQ share the goal to reduce complications post-discharge and more
effectively manage these patients as they navigate life after

About Omron Healthcare, Inc.

Omron Healthcare, the world’s leading manufacturer and
distributor of personal heart health and wellness products. Its
market-leading products include home blood pressure monitors and
electrotherapy devices. Since Omron invented its first blood pressure
monitors more than 40 years ago, the company has been passionate about
empowering people to take charge of their health at home through precise
technology. Omron is the number one doctor and pharmacist recommended
brand of blood pressure monitors for home use. The company’s mission is
Going for Zero, the elimination of heart attacks and strokes. For more
information, visit

About physIQ, Inc.

PhysIQ is a company dedicated to enabling proactive care delivery models
through pinpointIQ™, our highly scalable cloud-based platform for
personalized physiology analytics. Our FDA 510k-cleared data analytics
platform is designed to process multiple vital signs from wearable
sensors to create a personalized dynamic baseline for each individual.
By mapping vital sign relationships this way, physIQ’s analytics detect
subtle deviations that may be a precursor to disease exacerbation or
change in health. With applications in both healthcare and clinical
trial support, physIQ is transforming continuous physiological data into
insight for providers, health systems, payers, and pharmaceutical and
medical device companies. For more information, please visit
Follow us on Twitter and LinkedIn.


For physIQ:
Christa Carroll
Senior Vice President
Marketing Services
Ph: 630-408-9164

For Omron Healthcare:
Katherine Clark
Account Executive

error: Content is protected !!